Submitted by Anonymous (not verified) on 1 September 2026 - 12:40
Human medicines European public assessment report (EPAR): Aujemflu, Influenza vaccine (surface antigen, inactivated, adjuvanted, prepared in cell culture), Date of authorisation: 20/08/2026, Status: Authorised
Source: